ED Treatment denied as not medically necessary by Aetna?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for ed treatment are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on ED Treatment
## Why Aetna Denies ED Medication on Medical-Necessity Grounds
Aetna, like most large commercial insurers, applies a medical-necessity standard that requires the prescribing clinician to document that the medication is appropriate, necessary, and not merely convenient. For erectile dysfunction (ED) treatments, this standard is applied strictly because the therapy is sometimes classified as a "lifestyle" or "convenience" benefit depending on plan design. If the denial letter says "not medically necessary," that typically means Aetna's reviewer concluded that the clinical record did not sufficiently establish a diagnosed, documented condition warranting the specific agent requested.
## Why This Denial Is Appealable
ED is a recognized medical diagnosis with established guideline frameworks published by organizations such as the American Urological Association (AUA). When caused by an underlying condition — including but not limited to cardiovascular disease, diabetes, neurological conditions, post-surgical sequelae, or medication side effects — it carries clinical weight well beyond lifestyle inconvenience. A well-constructed appeal grounds the request in that medical context.
## Federal Appeal Framework
Your plan is subject to one or more of the following protections: - ACA §2719 / PPACA external review: For non-grandfathered group and individual plans, you have the right to an independent external review by a neutral third party. The window to request external review is typically around four months from the date of the final internal denial — verify the exact deadline on your denial letter. - ERISA §503 full-and-fair review: If your coverage is through an employer-sponsored plan, ERISA requires a full-and-fair internal review and creates a pathway to federal court if the denial is arbitrary. - Expedited review: If a standard timeline would seriously jeopardize your health or ability to function, you may request expedited internal and external review, often decided within 72 hours.
## Appeal Process and Timeline
1. Request the complete claim file and Aetna's clinical criteria document (the Coverage Policy Bulletin) for this drug category. 2. File a first-level internal appeal — Aetna's acknowledgment and decision timelines are stated on your denial notice. 3. If upheld, file a second-level internal appeal if available under your plan. 4. If still denied, file for independent external review before the four-month window closes.
## Documentation to Gather
- Diagnosis confirmation: Office notes, specialist records, or diagnostic test results establishing the ED diagnosis and any underlying contributing condition.
- Prior-treatment history: A dated log of any treatments previously tried, their doses, and why they were inadequate, discontinued, or contraindicated.
- Clinical severity: Chart language from the treating clinician describing severity, impact on quality of life, and functional impairment.
- Prescriber letter of medical necessity: A letter — written specifically for this appeal — explaining the clinical rationale, why this particular agent is appropriate, and why alternatives are insufficient.
- Applicable guideline reference: A citation to the relevant AUA or other recognized clinical guideline supporting the treatment approach (the organization and title, not a number you are asserting).
## Criteria-Mapping Structure
Obtain Aetna's published medical-necessity criteria for this drug category (available via the Coverage Policy Bulletin on Aetna's website or by written request). Then construct a table:
| Aetna Requirement | Documented Evidence in Chart | |---|---| | [Copy each criterion from Aetna's policy verbatim] | [Exact chart note, date, and provider that satisfies it] |
Every criterion must be addressed. Gaps invite re-denial.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →